(Q34544301)

2 August 2017

Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis (English)

1 reference

open-source drug discovery

2 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author

José Francisco García-Bustos

object named as

José Francisco García-Bustos

21

0 references

Lluís Ballell

object named as

Lluís Ballell

1

0 references

author name string

Robert H Bates

2

1 reference

2 August 2017

Rob J Young

3

1 reference

2 August 2017

Daniel Alvarez-Gomez

4

1 reference

2 August 2017

Emilio Alvarez-Ruiz

5

1 reference

2 August 2017

Vanessa Barroso

6

1 reference

2 August 2017

Delia Blanco

7

1 reference

2 August 2017

Benigno Crespo

8

1 reference

2 August 2017

Jaime Escribano

9

1 reference

2 August 2017

Rubén González

10

1 reference

2 August 2017

Sonia Lozano

11

1 reference

2 August 2017

Sophie Huss

12

1 reference

2 August 2017

Angel Santos-Villarejo

13

1 reference

2 August 2017

José Julio Martín-Plaza

14

1 reference

2 August 2017

Alfonso Mendoza

15

1 reference

2 August 2017

María José Rebollo-Lopez

16

1 reference

2 August 2017

Modesto Remuiñan-Blanco

17

1 reference

2 August 2017

José Luis Lavandera

18

1 reference

2 August 2017

Esther Pérez-Herran

19

1 reference

2 August 2017

Francisco Javier Gamo-Benito

20

1 reference

2 August 2017

David Barros

22

1 reference

2 August 2017

Julia P Castro

23

1 reference

2 August 2017

Nicholas Cammack

24

1 reference

2 August 2017

10 January 2013

1 reference

2 August 2017

1 reference

2 August 2017

8

1 reference

2 August 2017

2

1 reference

2 August 2017

313-321

1 reference

A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Challenges and opportunities in developing novel drugs for TB.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

The challenge of new drug discovery for tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Thousands of chemical starting points for antimalarial lead identification

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Antituberculosis activity of the molecular libraries screening center network library

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Discovery and validation of new antitubercular compounds as potential drug leads and probes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Unfinished business: target-based drug discovery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Drugs for bad bugs: confronting the challenges of antibacterial discovery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

The complete genome sequence of Mycobacterium bovis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3743164

Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.201200428

Multidrug- and extensively drug-resistant tuberculosis: an emerging threat

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.201200428

The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23307663

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Animal Models of Mycobacteria Infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23307663

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CMDC.201200428

1 reference

2 August 2017

1 reference

2 August 2017

1 reference